Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
Nasim HafeziGholamreza Azizi

Abstract

Autoimmune lymphoproliferative syndrome (ALPS) is a group of genetic disorders characterized by early-onset lymphoproliferation, autoimmune cytopenias, and susceptibility to lymphoma. The majority of ALPS patients carry heterozygous germline mutations in the TNFRSF6 gene. In this study, we conducted a systematic review of patients with ALPS and ALPS-like syndrome. The literature search was performed in Web of Science, Scopus, and PubMed databases to find eligible studies. Additionally, the reference list of all included papers was hand-searched for additional studies. Demographic, clinical, immunological, and molecular data were extracted and compared between the ALPS and ALPS-like syndrome. Totally, 720 patients with ALPS (532 genetically determined and 189 genetically undetermined ALPS) and 59 cases with ALPS-like phenotype due to mutations in genes other than ALPS genes were assessed. In both ALPS and ALPS-like patients, splenomegaly was the most common clinical presentation followed by autoimmune cytopenias and lymphadenopathy. Among other clinical manifestations, respiratory tract infections were significantly higher in ALPS-like patients than ALPS. The immunological analysis showed a lower serum level of IgA, IgG, and lym...Continue Reading

References

Jun 1, 1967·The Journal of Pediatrics·V C Canale, C H Smith
Sep 1, 1996·The Journal of Clinical Investigation·J WuJ D Mountz
Apr 9, 1998·International Immunology·Y KasaharaN Taniguchi
Mar 26, 1999·American Journal of Human Genetics·C E JacksonJ M Puck
May 9, 2003·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Hirokazu KaneganeToshio Miyawaki
Mar 16, 2005·American Journal of Ophthalmology·Wee-Kiak LimRobert B Nussenblatt
Sep 8, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·José C Crispín, George C Tsokos
Dec 25, 2010·The Journal of Clinical Investigation·Aude Magerus-ChatinetFrédéric Rieux-Laucat
Apr 15, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hye Sun KuehnJoão B Oliveira
Aug 5, 2014·Current Allergy and Asthma Reports·Shaili ShahTeresa K Tarrant
Jul 6, 2016·Immunology Letters·Serena Ilaria TripodiRaffaele Badolato
Jul 16, 2016·Blood·Carl E Allen
Jan 15, 2017·The Journal of Allergy and Clinical Immunology·Nourhen AgrebiImen Ben-Mustapha
Jul 3, 2017·Clinical Immunology : the Official Journal of the Clinical Immunology Society·N AgrebiM R Barbouche
Feb 13, 2018·Autoimmunity Reviews·D Brandt, C M Hedrich
Apr 9, 2019·Archives of Pathology & Laboratory Medicine·Daniel R Matson, David T Yang
Jun 14, 2019·Frontiers in Immunology·Andrea LiscoIrini Sereti
Jul 17, 2019·British Journal of Haematology·Maurizio MianoFrancesca Fioredda
Aug 23, 2019·Journal of Clinical Immunology·Deniz Cagdasİlhan Tezcan

❮ Previous
Next ❯

Citations

Jun 26, 2021·Biomedical Journal·Aude MagerusFrédéric Rieux-Laucat
Sep 11, 2021·Expert Review of Clinical Immunology·Michele P Lambert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Blood
Kenneth L McClain, Nitya Gulati
European Journal of Haematology
Manisha MadkaikarKanjaksha Ghosh
Cell Death and Differentiation
A Hague, L M Martins
Biomedical Journal
Frederic Rieux-LaucatDavid M Ojcius
© 2021 Meta ULC. All rights reserved